Has Louis Eichel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,047 in general payments to Louis Eichel, MD across 130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Louis Eichel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Louis Eichel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Louis Eichel, MD

Urology · Rochester, NYNPI 1588689772

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Johnson & Johnson at 59.9% of the total. Reporting peaked in 2022 at $6,340 and has fallen 90.3% since, to $617 in 2025.

$10,047in general payments, 2019–2025

Across 130 payments — averaging $77.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$6K
EDAP Technomed Inc$930
Astellas Pharma US Inc$477
Olympus America Inc.$336
Procept Biorobotics Corporation$308
Pfizer$241
plus $2K from 28 others

What the payments were for

Consulting fees$4,90049%
Travel & lodging$5766%
Food & beverage$4,37644%
Education$1952%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(3 entities)	15	$6,019
EDAP Technomed Inc	7	$930
Astellas Pharma US Inc	20	$477
Olympus America Inc.	6	$336
Procept Biorobotics Corporation	4	$308
Pfizer	15	$241
AbbVie(2 entities)	11	$214
Intuitive Surgical	3	$212
Laborie Medical Technologies Corp.	2	$183
Medtronic(2 entities)	7	$182
Organogenesis Inc.	1	$94
Calyxo, Inc.	1	$81
C. R. Bard, Inc. & Subsidiaries	2	$80
Biotissue Holdings Inc.	4	$76
Novartis	3	$74
Myriad Genetic Laboratories, Inc.	4	$58
Urogen Pharma, Inc.	2	$55
Bayer	2	$40
Axonics, Inc.	1	$38
Tolmar, Inc.	2	$37
Merck	2	$33
Zyla Life Sciences, Inc.	2	$32
Baxter Healthcare	1	$27
Ambu Inc.	2	$26
Boston Scientific	1	$22
Antares Pharma, Inc.	1	$22
Amniox Medical, Inc.	2	$21
Progenics Pharmaceuticals, Inc.	1	$21
Agiliti Surgical, Inc.	1	$20
Janssen Scientific Affairs, LLC	1	$20
Neotract Inc.	1	$18
Ferring Pharmaceuticals Inc.	1	$18
Novo Nordisk	1	$16
Tolmar Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,047 in reported general payments places this provider in the 80th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$78,922

Medicare patients

261

Services billed

1,401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	13	$1,223
Trospium Chloride	16	$1,144
Tamsulosin Hcl	47	$959
Finasteride	30	$605
Cephalexin	31	$234
Oxybutynin Chloride ErOxybutynin Chloride	13	$129
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	14	$111
Ciprofloxacin Hcl	19	$65
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$35

Paid to pharmacies, not to this prescriber.

Other urology in Rochester

Ahmed GhaziRochester$71K
Peter WalterJamestown$1.9M
Christopher PieczonkaSyracuse$797K
Bilal ChughtaiNew York$658K
Katie MurrayNew York$575K
Neil BanderNew York$544K
Robert ValenzuelaNew York$494K
Jeffrey SpencerCheektowaga$430K
Kyrollis AttallaNew York$381K
Benjamin BruckerNew York$364K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →